{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:31:15Z","timestamp":1793755875667,"version":"4.6.1"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cyto.2025.156954","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T16:57:57Z","timestamp":1746205077000},"page":"156954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The role of interleukin (IL)-2 cytokine family in Parkinson's disease"],"prefix":"10.1016","volume":"191","author":[{"given":"Pouya","family":"Goleij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin Khazeei","family":"Tabari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboube","family":"Hadipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantea Majma","family":"Sanaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalaf F.","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Daglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana\u00e9 S.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.26373","article-title":"Motor progression and nigrostriatal neurodegeneration in Parkinson disease","volume":"92","author":"Furukawa","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cyto.2025.156954_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.826193","article-title":"Evidence that substantia nigra pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active","volume":"16","author":"Ni","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.cyto.2025.156954_bb0015","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1177\/0269215520941142","article-title":"Dual-task training on gait, motor symptoms, and balance in patients with Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"34","author":"Li","year":"2020","journal-title":"Clin. Rehabil."},{"issue":"11","key":"10.1016\/j.cyto.2025.156954_bb0020","first-page":"679","article-title":"Parkinson disease","volume":"102","author":"Halli-Tierney","year":"2020","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","article-title":"Incidence of Parkinson disease in North America","volume":"8","author":"Willis","year":"2022","journal-title":"npj Parkinson's Disease"},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mds.28411","article-title":"Genetic and environmental factors in P arkinson\u2019s disease converge on immune function and inflammation","volume":"36","author":"Kline","year":"2021","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.cyto.2025.156954_bb0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/biom11040612","article-title":"Treatment options for motor and non-motor symptoms of Parkinson\u2019s disease","volume":"11","author":"Church","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.cyto.2025.156954_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-819973-2.00014-9","article-title":"Autonomic disorders in Parkinson disease: disrupted hypothalamic connectivity as revealed from resting-state functional magnetic resonance imaging","volume":"182","author":"Dayan","year":"2021","journal-title":"Handb. Clin. Neurol."},{"issue":"6","key":"10.1016\/j.cyto.2025.156954_bb0050","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.cyto.2025.156954_bb0055","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1212\/WNL.0000000000009946","article-title":"Deep brain stimulation in early-stage Parkinson disease: five-year outcomes","volume":"95","author":"Hacker","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.cyto.2025.156954_bb0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.cr.7310027","article-title":"Regulation of cytokine signaling pathways by PIAS proteins","volume":"16","author":"Shuai","year":"2006","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0065","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ajpath.2020.05.007","article-title":"The surprising story of IL-2: from experimental models to clinical application","volume":"190","author":"Abbas","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2025.156954_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156638","article-title":"The role of IL-2 cytokine family in asthma","volume":"180","author":"Goleij","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2025.156954_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2023.104645","article-title":"Interleukin-2 family cytokines: An overview of genes, expression, signaling and functional roles in teleost","volume":"141","author":"Zhang","year":"2023","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2022.06.004","article-title":"The IL-2A receptor pathway and its role in lymphocyte differentiation and function","volume":"67","author":"Li","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"issue":"12","key":"10.1016\/j.cyto.2025.156954_bb0085","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/cancers12123586","article-title":"Immunomodulatory effects of IL-2 and IL-15; implications for cancer immunotherapy","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.cyto.2025.156954_bb0090","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/cancers12061591","article-title":"Transcriptional regulation of natural killer cell development and functions","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0095","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202254677","article-title":"IL-21 has a critical role in establishing germinal centers by amplifying early B cell proliferation","volume":"23","author":"Dvorscek","year":"2022","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.cyto.2025.156954_bb0100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1189\/jlb.1107778","article-title":"The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells","volume":"84","author":"Wuest","year":"2008","journal-title":"J. Leucocyte Biology"},{"issue":"2","key":"10.1016\/j.cyto.2025.156954_bb0105","doi-asserted-by":"crossref","first-page":"fcaa112","DOI":"10.1093\/braincomms\/fcaa112","article-title":"Restoring regulatory T-cell dysfunction in Alzheimer\u2019s disease through ex vivo expansion","volume":"2","author":"Faridar","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.cyto.2025.156954_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson\u2019s disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"\u00c1lvarez-Luqu\u00edn","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0115","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/brainsci12091237","article-title":"Alzheimer\u2019s disease and inflammaging","volume":"12","author":"Kosyreva","year":"2022","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.cyto.2025.156954_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cytogfr.2014.07.018","article-title":"The IL-2 cytokine family in cancer immunotherapy","volume":"25","author":"Sim","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.cyto.2025.156954_bb0125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor","volume":"22","author":"Liu","year":"2021","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2025.156954_bb0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1517\/13543776.15.5.521","article-title":"Interleukin-2 family cytokines: potential for therapeutic immmunoregulation","volume":"15","author":"Dumont","year":"2005","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.cyto.2025.156954_bb0135","doi-asserted-by":"crossref","first-page":"1090311","DOI":"10.3389\/fimmu.2023.1090311","article-title":"The application of Interleukin-2 family cytokines in tumor immunotherapy research","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108515","article-title":"The IL-2\u2013IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor","volume":"218","author":"Damoiseaux","year":"2020","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2025.156954_bb0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.molmed.2022.04.010","article-title":"Therapeutic potential of interleukin-2 in autoimmune diseases","volume":"28","author":"Yuan","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cyto.2025.156954_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696350","article-title":"Case report: interleukin-2 receptor common gamma chain defect presented as a hyper-IgE syndrome","volume":"12","author":"Belaid","year":"2021","journal-title":"Front. Immunol."},{"issue":"561","key":"10.1016\/j.cyto.2025.156954_bb0155","doi-asserted-by":"crossref","first-page":"eaba5464","DOI":"10.1126\/scitranslmed.aba5464","article-title":"Interleukin-2 signals converge in a lymphoid\u2013dendritic cell pathway that promotes anticancer immunity","volume":"12","author":"Raeber","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.cyto.2025.156954_bb0160","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.4049\/jimmunol.2100764","article-title":"IL-2 signaling couples the MAPK and mTORC1 axes to promote T cell proliferation and differentiation in teleosts","volume":"208","author":"Mu","year":"2022","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12943-023-01826-7","article-title":"Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies","volume":"22","author":"Muhammad","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cyto.2025.156954_bb0170","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3389\/fimmu.2019.03100","article-title":"Treg heterogeneity, function, and homeostasis","volume":"10","author":"Shevyrev","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.531785","article-title":"Interleukin-2 (IL-2) interacts with IL-2 receptor beta (IL-2R\u03b2): its potential to enhance the proliferation of CD4+ T lymphocytes in flounder (Paralichthys olivaceus)","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0180","series-title":"CD4+ T-cell differentiation in vitro","first-page":"91","author":"Yang","year":"2020"},{"issue":"10","key":"10.1016\/j.cyto.2025.156954_bb0185","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.immuni.2021.08.028","article-title":"Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation","volume":"54","author":"Duan","year":"2021","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.cyto.2025.156954_bb0190","first-page":"4199","article-title":"Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanisms, Blood","volume":"118","author":"Balce","year":"2011","journal-title":"The Journal of the American Society of Hematology"},{"key":"10.1016\/j.cyto.2025.156954_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156049","article-title":"IL-7: comprehensive review","volume":"160","author":"Winer","year":"2022","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41577-020-0396-0","article-title":"IL-9-producing T cells: potential players in allergy and cancer","volume":"21","author":"Angkasekwinai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2025.156954_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009121","article-title":"IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2-and IL-9-driven mast cell activation","volume":"16","author":"Meiners","year":"2020","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.cyto.2025.156954_bb0210","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","article-title":"Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12885-023-11806-1","article-title":"Co-expression of IL-21-enhanced NKG2D CAR-NK cell therapy for lung cancer","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cancer"},{"issue":"80","key":"10.1016\/j.cyto.2025.156954_bb0220","doi-asserted-by":"crossref","first-page":"eadd1728","DOI":"10.1126\/sciimmunol.add1728","article-title":"Heparan sulfate regulates IL-21 bioavailability and signal strength that control germinal center B cell selection and differentiation","volume":"8","author":"Chen","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0225","article-title":"Chemotherapeutic effects of Apigenin in breast cancer: preclinical evidence and molecular mechanisms; enhanced bioavailability by nanoparticles","volume":"34","author":"Adel","year":"2022","journal-title":"Biotechnol. Rep."},{"issue":"5","key":"10.1016\/j.cyto.2025.156954_bb0230","article-title":"Dysregulation of the adaptive immune system in patients with early-stage Parkinson disease","volume":"8","author":"Yan","year":"2021","journal-title":"Neurol: Neuroimmunol. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.cyto.2025.156954_bb0235","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1093\/brain\/awad064","article-title":"Impaired dopamine release in Parkinson\u2019s disease","volume":"146","author":"Cramb","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.cyto.2025.156954_bb0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cyto.2025.156954_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02309-6","article-title":"The semantics of microglia activation: neuroinflammation, homeostasis, and stress","volume":"18","author":"Woodburn","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.cyto.2025.156954_bb0250","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","article-title":"Microglia: Immune and non-immune functions","volume":"54","author":"Borst","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2025.156954_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105094","article-title":"Activated microglia facilitate the transmission of \u03b1-synuclein in Parkinson\u2019s disease","volume":"148","author":"Zheng","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cyto.2025.156954_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105014","article-title":"Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson\u2019s disease: the therapeutic role of Nrf2 activators","volume":"145","author":"Jayaram","year":"2021","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0265","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12974-022-02410-4","article-title":"Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson\u2019s disease","volume":"19","author":"Pike","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.cyto.2025.156954_bb0270","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","article-title":"Function and therapeutic value of astrocytes in neurological diseases","volume":"21","author":"Lee","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0275","first-page":"1890","article-title":"Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer\u2019s disease","volume":"18","author":"Yue","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.cyto.2025.156954_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.cyto.2025.156954_bb0285","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cells9122623","article-title":"Neuron-astrocyte interactions in Parkinson\u2019s disease","volume":"9","author":"Miyazaki","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2025.156954_bb0290","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s11481-020-09926-7","article-title":"Neuroinflammatory responses and Parkinson\u2019disease: pathogenic mechanisms and therapeutic targets","volume":"15","author":"Yang","year":"2020","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0295","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11064-019-02743-2","article-title":"Astroglia in sepsis associated encephalopathy","volume":"45","author":"Shulyatnikova","year":"2020","journal-title":"Neurochem. Res."},{"issue":"6","key":"10.1016\/j.cyto.2025.156954_bb0300","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cyto.2025.156954_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105700","article-title":"Immune responses in the Parkinson\u2019s disease brain","volume":"168","author":"Weiss","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cyto.2025.156954_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.636139","article-title":"Genetic defects and pro-inflammatory cytokines in Parkinson\u2019s disease","volume":"12","author":"Magnusen","year":"2021","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.cyto.2025.156954_bb0315","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0320","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-022-00563-7","article-title":"CD8+ T cells in neurodegeneration: friend or foe?","volume":"17","author":"Hu","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0325","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":"\u0391-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cyto.2025.156954_bb0330","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2025.156954_bb0335","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","article-title":"Reduced T helper and B lymphocytes in Parkinson\u2019s disease","volume":"252","author":"Stevens","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00509-5","article-title":"Pathological \u03b1-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain","volume":"17","author":"Xu","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.cyto.2025.156954_bb0345","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/mds.28424","article-title":"Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson\u2019s disease","volume":"36","author":"Nissen","year":"2021","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.cyto.2025.156954_bb0350","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson\u2019s disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"issue":"6512","key":"10.1016\/j.cyto.2025.156954_bb0355","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.cyto.2025.156954_bb0360","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1177\/0271678X16642233","article-title":"Blood\u2013brain barrier breakdown promotes macrophage infiltration and cognitive impairment in leptin receptor-deficient mice","volume":"36","author":"Stranahan","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cyto.2025.156954_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.593026","article-title":"Blood\u2013brain barrier leakage is increased in Parkinson\u2019s disease","volume":"11","author":"Al-Bachari","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0370","first-page":"1","article-title":"VEGFA mediates blood\u2013brain barrier disruption in Parkinson disease","volume":"18","author":"Wood","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.cyto.2025.156954_bb0375","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41584-021-00707-x","article-title":"Interleukin-2 and regulatory T cells in rheumatic diseases","volume":"17","author":"Kolios","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.cyto.2025.156954_bb0380","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2024.07.024","article-title":"Interleukin-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma","volume":"154","author":"Bick","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2025.156954_bb0385","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/molecules27103194","article-title":"Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases","volume":"27","author":"Rauf","year":"2022","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.cyto.2025.156954_bb0390","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.3390\/ijms21072431","article-title":"Exploring the etiological links behind neurodegenerative diseases: inflammatory cytokines and bioactive kynurenines","volume":"21","author":"Tanaka","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21705\/mcbs.v4i1.64","article-title":"Impaired function of regulatory T cells in type 2 diabetes mellitus","volume":"4","author":"Kartika","year":"2020","journal-title":"Mol. Cellular Biomed. Sci."},{"issue":"22","key":"10.1016\/j.cyto.2025.156954_bb0400","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.3390\/ijms232213856","article-title":"Low-dose IL-2 attenuated depression-like behaviors and pathological changes through restoring the balances between IL-6 and TGF-\u03b2 and between Th17 and Treg in a chronic stress-induced mouse model of depression","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0405","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12967-022-03570-w","article-title":"Dual roles of interleukin-33 in cognitive function by regulating central nervous system inflammation","volume":"20","author":"Rao","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2025.156954_bb0410","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molimm.2019.11.011","article-title":"Control of memory CD8+ T cell longevity and effector functions by IL-15","volume":"117","author":"Nolz","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0415","doi-asserted-by":"crossref","unstructured":"L. Wu, N.-n. Ji, H. Wang, J.-y. Hua, G.-l. Sun, P.-p. Chen, R. Hua, Y.-m. Zhang, Domino effect of Interleukin-15 and CD8 T-cell\u2013mediated neuronal apoptosis in experimental traumatic brain injury, J. Neurotrauma 38(10) (2021) 1450\u20131463.","DOI":"10.1089\/neu.2017.5607"},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0420","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1039\/D2MO00105E","article-title":"Metabolic responses in the cortex and hippocampus induced by Il-15r\u03b1 mutation","volume":"18","author":"He","year":"2022","journal-title":"Molecular Omics"},{"issue":"23","key":"10.1016\/j.cyto.2025.156954_bb0425","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1111\/jcmm.15266","article-title":"IFN-\u03b3+ IL-17+ Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma","volume":"24","author":"Xing","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0430","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2025.156954_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0440","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","article-title":"Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis","volume":"10","author":"Jin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2025.156954_bb0445","article-title":"Th17 cells and inflammation in neurological disorders: possible mechanisms of action","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0450","article-title":"\u0393\u03b4 T cell in cerebral ischemic stroke: characteristic, immunity-inflammatory role, and therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.cyto.2025.156954_bb0455","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3390\/ijms24032909","article-title":"Endothelial dysfunction in neurodegenerative diseases","volume":"24","author":"Fang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2025.156954_bb0460","article-title":"Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-86","article-title":"Diverse activation of microglia by chemokine (CC motif) ligand 2 overexpression in brain","volume":"10","author":"Selenica","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0470","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202717","article-title":"Microglia in Alzheimer\u2019s disease at single-cell level. Are there common patterns in humans and mice?","volume":"218","author":"Chen","year":"2021","journal-title":"J. Exp. Med."},{"issue":"s1","key":"10.1016\/j.cyto.2025.156954_bb0475","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.3233\/JPD-223237","article-title":"Microglia in Parkinson\u2019s disease","volume":"12","author":"Stefanova","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.cyto.2025.156954_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.885500","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: from mechanistic insights to therapy","volume":"14","author":"Gao","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0490","doi-asserted-by":"crossref","first-page":"9069870","DOI":"10.1155\/2024\/9069870","article-title":"Assessing the causal relationship between genetically determined inflammatory cytokines and Parkinson\u2019s disease risk: a bidirectional two-sample Mendelian randomization study","volume":"2024","author":"Xue","year":"2024","journal-title":"J Immunol Res"},{"issue":"8","key":"10.1016\/j.cyto.2025.156954_bb0495","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.3390\/ijms23084148","article-title":"Biomarker of neuroinflammation in Parkinson\u2019s disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2025.156954_bb0500","doi-asserted-by":"crossref","DOI":"10.1177\/2398212819901082","article-title":"The role of the immune system in driving neuroinflammation","volume":"4","author":"N\u00ed Chasaide","year":"2020","journal-title":"Brain Neurosci. Adv."},{"issue":"8","key":"10.1016\/j.cyto.2025.156954_bb0505","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/antiox9080743","article-title":"ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease","volume":"9","author":"Simpson","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.cyto.2025.156954_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02065-z","article-title":"Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson\u2019s disease model","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cyto.2025.156954_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.cyto.2025.156954_bb0520","doi-asserted-by":"crossref","first-page":"466","DOI":"10.14336\/AD.2020.0701","article-title":"Microglial polarization: novel therapeutic strategy against ischemic stroke","volume":"12","author":"Xue","year":"2021","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.cyto.2025.156954_bb0525","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/cei\/uxac105","article-title":"IL-2-based approaches to Treg enhancement","volume":"211","author":"Harris","year":"2023","journal-title":"Clin. Exp. Immunol."},{"issue":"43","key":"10.1016\/j.cyto.2025.156954_bb0530","doi-asserted-by":"crossref","first-page":"eabn1298","DOI":"10.1126\/sciadv.abn1298","article-title":"Regulation of \u03b1-synuclein homeostasis and inflammasome activation by microglial autophagy","volume":"8","author":"Choi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cyto.2025.156954_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155556","article-title":"Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment","volume":"144","author":"Yap","year":"2021","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.cyto.2025.156954_bb0540","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/epi.17023","article-title":"Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology","volume":"62","author":"Alvim","year":"2021","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0545","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/brainsci12091154","article-title":"The interrelation between Interleukin-2 and schizophrenia","volume":"12","author":"Huang","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.cyto.2025.156954_bb0550","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2020.03.008","article-title":"IL-4 switches microglia\/macrophage M1\/M2 polarization and alleviates neurological damage by modulating the JAK1\/STAT6 pathway following ICH","volume":"437","author":"He","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.cyto.2025.156954_bb0555","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s11011-015-9714-9","article-title":"Role for microglia in sex differences after ischemic stroke: importance of M2","volume":"30","author":"Bodhankar","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.cyto.2025.156954_bb0560","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2020.06.006","article-title":"Exogenous IL-4 shuts off pro-inflammation in neutrophils while stimulating anti-inflammation in macrophages to induce neutrophil phagocytosis following myocardial infarction","volume":"145","author":"Daseke","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.cyto.2025.156954_bb0565","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/cells9071717","article-title":"Microglia: agents of the CNS pro-inflammatory response","volume":"9","author":"Rodr\u00edguez-G\u00f3mez","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cyto.2025.156954_bb0570","doi-asserted-by":"crossref","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0575","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-022-00282-2","article-title":"Transcriptional analysis of peripheral memory T cells reveals Parkinson\u2019s disease-specific gene signatures, npj","volume":"8","author":"Dhanwani","year":"2022","journal-title":"Parkinson\u2019s Disease"},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0580","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12890-022-01976-2","article-title":"The absence of IL-9 reduces allergic airway inflammation by reducing ILC2, Th2 and mast cells in murine model of asthma","volume":"22","author":"Li","year":"2022","journal-title":"BMC Pulm. Med."},{"issue":"2","key":"10.1016\/j.cyto.2025.156954_bb0585","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3892\/etm.2020.8789","article-title":"Mast cell-mediated neuroinflammation may have a role in attention deficit hyperactivity disorder","volume":"20","author":"Song","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cyto.2025.156954_bb0590","article-title":"Transcription factors associated with IL-15 cytokine signaling during NK cell development","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2025.156954_bb0595","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/STROKEAHA.119.028638","article-title":"IL (interleukin)-15 bridges astrocyte-microglia crosstalk and exacerbates brain injury following intracerebral hemorrhage","volume":"51","author":"Shi","year":"2020","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.cyto.2025.156954_bb0600","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.it.2016.06.001","article-title":"IL-21 and T cell differentiation: consider the context","volume":"37","author":"Tian","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2025.156954_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.572205","article-title":"Imbalance of circulating Tfh\/Tfr cells in patients with Parkinson\u2019s disease","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.cyto.2025.156954_bb0610","first-page":"572","article-title":"Levodopa therapy for Parkinson's disease: history, current status and perspectives","volume":"19","author":"Bogetofte","year":"2020","journal-title":"CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"issue":"5","key":"10.1016\/j.cyto.2025.156954_bb0615","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(24)00052-8","article-title":"Safety and efficacy of continuous subcutaneous levodopa\u2013carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial","volume":"23","author":"Espay","year":"2024","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1016\/j.cyto.2025.156954_bb0620","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-023-02647-0","article-title":"Role of dopamine agonists in Parkinson\u2019s disease therapy","volume":"130","author":"Woitalla","year":"2023","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.cyto.2025.156954_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.806618","article-title":"The signaling and pharmacology of the dopamine D1 receptor","volume":"15","author":"Jones-Tabah","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"18","key":"10.1016\/j.cyto.2025.156954_bb0630","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1080\/14656566.2020.1805432","article-title":"An update on the use of non-ergot dopamine agonists for the treatment of Parkinson\u2019s disease","volume":"21","author":"Cerri","year":"2020","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.cyto.2025.156954_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.773404","article-title":"Development and clinical application of positron emission tomography imaging agents for monoamine oxidase B","volume":"15","author":"Meyer","year":"2022","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.cyto.2025.156954_bb0640","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JPD-212976","article-title":"Monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease: past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0645","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41531-022-00339-2","article-title":"Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson\u2019s disease: a systematic review, npj","volume":"8","author":"Tsuboi","year":"2022","journal-title":"Parkinson\u2019s Disease"},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0650","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/14737175.2021.1968298","article-title":"Redefining the strategy for the use of COMT inhibitors in Parkinson\u2019s disease: the role of opicapone","volume":"21","author":"Jenner","year":"2021","journal-title":"Expert. Rev. Neurother."},{"issue":"8","key":"10.1016\/j.cyto.2025.156954_bb0655","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/mdc3.13347","article-title":"Antimuscarinic anticholinergic medications in Parkinson disease: to prescribe or deprescribe?","volume":"8","author":"Barrett","year":"2021","journal-title":"Movement Disorders Clinical Practice"},{"issue":"7","key":"10.1016\/j.cyto.2025.156954_bb0660","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/molecules27072366","article-title":"The pharmacological potential of adenosine A2A receptor antagonists for treating Parkinson\u2019s disease","volume":"27","author":"Mori","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.cyto.2025.156954_bb0665","doi-asserted-by":"crossref","first-page":"185","DOI":"10.14802\/jmd.20052","article-title":"Update on current technologies for deep brain stimulation in Parkinson\u2019s disease","volume":"13","author":"Paff","year":"2020","journal-title":"J. Movement Disorders"},{"issue":"4","key":"10.1016\/j.cyto.2025.156954_bb0670","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/mds.27996","article-title":"Debugging adaptive deep brain stimulation for Parkinson\u2019s disease","volume":"35","author":"Little","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cyto.2025.156954_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120193","article-title":"Focused ultrasound and other lesioning in the treatment of tremor","volume":"435","author":"Binder","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2025.156954_bb0680","doi-asserted-by":"crossref","first-page":"2251145","DOI":"10.1080\/07853890.2023.2251145","article-title":"Low intensity focused ultrasound: a new prospect for the treatment of Parkinson\u2019s disease","volume":"55","author":"Zhong","year":"2023","journal-title":"Ann. Med."},{"issue":"4","key":"10.1016\/j.cyto.2025.156954_bb0685","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3171\/2022.1.JNS212449","article-title":"Pretherapeutic functional connectivity of tractography-based targeting of the ventral intermediate nucleus for predicting tremor response in patients with Parkinson\u2019s disease after thalamotomy with MRI-guided focused ultrasound","volume":"137","author":"Xiong","year":"2022","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0690","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/nipt-2022-0001","article-title":"Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's disease","volume":"1","author":"Markovic","year":"2022","journal-title":"NeuroImmune Pharm Ther"},{"key":"10.1016\/j.cyto.2025.156954_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111273","article-title":"IL-2\/anti-IL-2 complexes attenuates neuroinflammation and neurodegeneration in mice of experimental Parkinson\u2019s disease","volume":"223","author":"Li","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.cyto.2025.156954_bb0700","doi-asserted-by":"crossref","unstructured":"J. Liu, Y. Liang, Q. Meng, J. Chen, J. Ma, H. Zhu, L. Cai, N. Song, J. Ding, Y. Fan, M. Lu, G. Wu, Y. Fang, G. Hu, Antagonism of \u03b2-arrestins in IL-4\u2013driven microglia reactivity via the Samd4\/mTOR\/OXPHOS axis in Parkinson's disease, Sci. Adv. 10(34) eadn4845.","DOI":"10.1126\/sciadv.adn4845"},{"key":"10.1016\/j.cyto.2025.156954_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00062","article-title":"Interleukin-4 protects dopaminergic neurons in vitro but is dispensable for MPTP-induced neurodegeneration in vivo","volume":"10","author":"H\u00fchner","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.cyto.2025.156954_bb0710","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s10072-012-1284-6","article-title":"Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson\u2019s disease","volume":"34","author":"Chen","year":"2013","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.cyto.2025.156954_bb0715","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2025.156954_bb0720","doi-asserted-by":"crossref","first-page":"10650","DOI":"10.1038\/s41598-020-67649-4","article-title":"Parkinsonian neurotoxicants impair the anti-inflammatory response induced by IL4 in glial cells: involvement of the CD200-CD200R1 ligand-receptor pair","volume":"10","author":"Rabaneda-Lombarte","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T14:25:25Z","timestamp":1753539925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625001012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":144,"alternative-id":["S1043466625001012"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156954","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of interleukin (IL)-2 cytokine family in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156954"}}